Oxidative Stress-Mediated Neuroinflammation in the Pathophysiology of Schizophrenia
International Journal of Molecular Sciences · 18.11.2025 · 26 (22) · 11139
DOI: 10.3390/ijms262211139 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 18.11.2025. Verfasst von Mateusz Trubalski und 7 weiteren Autor:innen. Beteiligte Einrichtung: Student Scientific Association at the Department of Normal, Clinical and Imaging Anatomy, Medical University of Lublin, 20-090 Lublin, Poland. Hauptthemen laut MEDLINE: Schizophrenia, Oxidative Stress, Neuroinflammatory Diseases. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 165 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Schizophrenia is a complex neuropsychiatric disorder characterized by a diverse range of symptoms, including positive, negative symptoms such as alogia, anhedonia, avolition, and affective flattening, cognitive symptoms, and emotional symptoms as a separate domain. Emerging evidence suggests that oxidative stress and neuroinflammation play crucial roles in the etiopathogenesis of schizophrenia. The aim of this review is the interplay between oxidative stress—defined as an imbalance between reactive oxygen species (ROS) production and antioxidant defenses—and neuroinflammatory processes within the central nervous system. Studies indicate that elevated levels of oxidative markers and pro-inflammatory cytokines are commonly observed in individuals with schizophrenia, pointing to a potential pathophysiological link. The dysregulation of redox homeostasis may exacerbate neuroinflammatory responses, contributing to neuronal damage and the subsequent manifestation of psychiatric symptoms. Furthermore, genetic and environmental factors may interact with these biological processes, influencing individual susceptibility to schizophrenia. Understanding the mechanisms by which oxidative stress and neuroinflammation contribute to the development and progression of schizophrenia could pave the way for novel therapeutic strategies aimed at mitigating these pathological processes and improving patient outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Student Scientific Association at the Department of Normal, Clinical and Imaging Anatomy, Medical University of Lublin, 20-090 Lublin, Poland.
- Department of Normal, Clinical and Imaging Anatomy, Medical University of Lublin, 20-090 Lublin, Poland.
- Occupational Therapy Laboratory, Chair of Nursing Development, Medical University of Lublin, 20-081 Lublin, Poland.
- Department of Psychiatry, Medical University of Warsaw, 02-091 Warsaw, Poland.
- Department of Animal Physiology, Faculty of Veterinary Medicine, University of Life Sciences in Lublin, 20-950 Lublin, Poland.
ORCID-Profile: Mateusz Trubalski, Agnieszka Markiewicz-Gospodarek, Julia Poleszak, Miłosz Szczotka, Renata Markiewicz, Sylwia Szymańczyk
Zitieren
APA
Trubalski, M., Markiewicz-Gospodarek, A., Żerebiec, M., Poleszak, J., Szczotka, M., Markiewicz, R., Łoza, B., & Szymańczyk, S. (2025). Oxidative Stress-Mediated Neuroinflammation in the Pathophysiology of Schizophrenia. International Journal of Molecular Sciences, 26(22), 11139. https://doi.org/10.3390/ijms262211139
Vancouver
Trubalski M, Markiewicz-Gospodarek A, Żerebiec M, Poleszak J, Szczotka M, Markiewicz R, et al. Oxidative Stress-Mediated Neuroinflammation in the Pathophysiology of Schizophrenia. International Journal of Molecular Sciences. 2025;26(22):11139. doi:10.3390/ijms262211139
BibTeX
@article{Trubalski2025,
author = {Trubalski, Mateusz and Markiewicz-Gospodarek, Agnieszka and Żerebiec, Marta and Poleszak, Julia and Szczotka, Miłosz and Markiewicz, Renata and Łoza, Bartosz and Szymańczyk, Sylwia},
title = {Oxidative Stress-Mediated Neuroinflammation in the Pathophysiology of Schizophrenia},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {22},
pages = {11139},
doi = {10.3390/ijms262211139}
}
EUVIMED